{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:15:48Z","timestamp":1791875748070,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019944","name":"Sanofi Aventis GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019944","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011852","name":"Paracelsus Medizinische Privatuniversitat","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011852","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.numecd.2026.104618","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:11:01Z","timestamp":1770826261000},"page":"104618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Atherosclerosis burden across subtypes of steatotic liver disease: a European cohort analysis"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5134-4137","authenticated-orcid":false,"given":"Johannes","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gensluckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Eberhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Akhgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Datz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Iglseder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Langthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Trinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Ausserwinkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Semmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Paulweber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Wernly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.numecd.2026.104618_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.numecd.2026.104618_bib2","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.numecd.2026.104618_bib3","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American association for the study of liver diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.numecd.2026.104618_bib4","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"24","key":"10.1016\/j.numecd.2026.104618_bib5","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/cells13242055","article-title":"Exploring the role of peroxisome proliferator-activated receptors and endothelial dysfunction in metabolic dysfunction-associated steatotic liver disease","volume":"13","author":"Madariaga","year":"2024","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.numecd.2026.104618_bib6","doi-asserted-by":"crossref","DOI":"10.4330\/wjc.v17.i6.106147","article-title":"Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: a review of pathogenesis","volume":"17","author":"Bharaj","year":"2025","journal-title":"World J Cardiol"},{"issue":"9","key":"10.1016\/j.numecd.2026.104618_bib7","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.numecd.2026.104618_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4330\/wjc.v6.i5.245","article-title":"Alcohol-induced hypertension: mechanism and prevention","volume":"6","author":"Husain","year":"2014","journal-title":"World J Cardiol"},{"key":"10.1016\/j.numecd.2026.104618_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.vph.2015.04.002","article-title":"Angiotensin type 1 receptor mediates chronic ethanol consumption-induced hypertension and vascular oxidative stress","volume":"74","author":"Passaglia","year":"2015","journal-title":"Vasc Pharmacol"},{"issue":"2","key":"10.1016\/j.numecd.2026.104618_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1530-0277.2011.01636.x","article-title":"Endothelial dysfunction and high cardiovascular risk profile in severe alcoholics improve only partially following a medium-term alcohol withdrawal","volume":"36","author":"Di Gennaro","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.numecd.2026.104618_bib11","first-page":"518","article-title":"Inhibition of the myogenic response in human cerebral arteries by ethanol","volume":"35","author":"Kuhlmann","year":"2004","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.numecd.2026.104618_bib12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1148\/rg.210122","article-title":"Coronary artery calcium scoring: current status and future directions","volume":"42","author":"Gupta","year":"2022","journal-title":"Radiographics"},{"key":"10.1016\/j.numecd.2026.104618_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2025.7567","article-title":"What is a cardiac CT calcium score?","author":"Walter","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2026.104618_bib14","article-title":"Role of coronary artery calcium score in the primary prevention of cardiovascular disease","volume":"373","author":"Nasir","year":"2021","journal-title":"Br Med J"},{"issue":"24","key":"10.1016\/j.numecd.2026.104618_bib15","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2026.104618_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ahj.2023.07.008","article-title":"Prognostic value of coronary artery calcium score for the prediction of atherosclerotic cardiovascular disease in participants with suspected nonalcoholic hepatic steatosis: results from the multi-ethnic study of atherosclerosis","volume":"265","author":"Ichikawa","year":"2023","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.numecd.2026.104618_bib17","first-page":"567","article-title":"Prevalence of subclinical cardiovascular disease in patients with non-alcoholic-fatty liver disease: analysis of the paracelsus 10.000 cohort study","volume":"32","author":"Koutny","year":"2023","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.numecd.2026.104618_bib18","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2012.13705","article-title":"Carotid intima-media thickness as a biomarker of subclinical atherosclerosis","volume":"142","author":"Bauer","year":"2012","journal-title":"Swiss Med Wkly"},{"issue":"13","key":"10.1016\/j.numecd.2026.104618_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029656","article-title":"Age-related trends in the predictive value of carotid intima-media thickness for cardiovascular death: a prospective population-based cohort study","volume":"12","author":"Ge","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.numecd.2026.104618_bib20","first-page":"e596","article-title":"ACC\/AHA guideline on the primary prevention of cardiovascular disease","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2026.104618_bib21","first-page":"1","article-title":"Paracelsus 10 000: an observational cohort study about the health status of the population of Salzburg, Austria. Rationale, objectives and study design","author":"Frey","year":"2023","journal-title":"Paracelsus Proceedings of Experimental Medicine"},{"issue":"Suppl 1","key":"10.1016\/j.numecd.2026.104618_bib22","first-page":"S59","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in Diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.numecd.2026.104618_bib23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/HEP.0000000000000845","article-title":"AASLD practice guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis","volume":"81","author":"Sterling","year":"2025","journal-title":"Hepatology"},{"issue":"10464","key":"10.1016\/j.numecd.2026.104618_bib24","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.numecd.2026.104618_bib25","first-page":"e93","article-title":"Polygenic risk scores for cardiovascular disease: a scientific statement from the American heart association","volume":"146","author":"O'Sullivan","year":"2022","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.numecd.2026.104618_bib26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jama.2019.21782","article-title":"Predictive accuracy of a polygenic risk score compared with a clinical risk score for incident coronary heart disease","volume":"323","author":"Mosley","year":"2020","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.numecd.2026.104618_bib27","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1001\/jama.2023.7575","article-title":"Coronary artery calcium score and polygenic risk score for the prediction of coronary heart disease events","volume":"329","author":"Khan","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.numecd.2026.104618_bib28","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/CIRCRESAHA.120.315928","article-title":"Polygenic scores to assess atherosclerotic cardiovascular disease risk: clinical perspectives and basic implications","volume":"126","author":"Aragam","year":"2020","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.numecd.2026.104618_bib29a","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/jama.2019.22241","article-title":"Predictive accuracy of a polygenic risk score-enhanced prediction model vs a clinical risk score for coronary artery disease","volume":"323","author":"Elliott","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.numecd.2026.104618_bib29b","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301126","article-title":"Steatotic liver disease and its newly proposed sub-classifications correlate with progression of the coronary artery calcium score","volume":"19","author":"Kim","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2026.104618_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.125.050961","article-title":"Genetic risk scores in stroke research and care","author":"Bragazzi","year":"2025","journal-title":"Stroke"},{"issue":"24","key":"10.1016\/j.numecd.2026.104618_bib31","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American heart association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.numecd.2026.104618_bib32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3350\/cmh.2021.0406","article-title":"Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: an updated meta-analysis with 135,602 participants","volume":"28","author":"Tang","year":"2022","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"10.1016\/j.numecd.2026.104618_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/gutjnl-2016-311854","article-title":"Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study","volume":"66","author":"Sinn","year":"2017","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.numecd.2026.104618_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301126","article-title":"Steatotic liver disease and its newly proposed sub-classifications correlate with progression of the coronary artery calcium score","volume":"19","author":"Kim","year":"2024","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.numecd.2026.104618_bib35","article-title":"Increased prevalence of high-risk coronary plaques in metabolic dysfunction-associated steatotic liver disease patients: a meta-analysis","volume":"54","author":"De Filippo","year":"2024","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.numecd.2026.104618_bib36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/apt.17869","article-title":"Systematic review with meta-analysis: Steatosis severity and subclinical atherosclerosis in metabolic dysfunction-associated steatotic liver disease","volume":"59","author":"Jamalinia","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.numecd.2026.104618_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-10380-9","article-title":"Association of metabolic dysfunction-associated steatotic liver disease and steatosis-associated fibrosis estimator with subclinical coronary atherosclerosis: observation cohort study","volume":"15","author":"Jeong","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.numecd.2026.104618_bib38","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1186\/s12967-024-05478-z","article-title":"Polygenic risk score of metabolic dysfunction-associated steatotic liver disease amplifies the health impact on severe liver disease and metabolism-related outcomes","volume":"22","author":"Xiao","year":"2024","journal-title":"J Transl Med"},{"issue":"7","key":"10.1016\/j.numecd.2026.104618_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186424","article-title":"Human genetics of metabolic dysfunction-associated steatotic liver disease: from variants to cause to precision treatment","volume":"135","author":"Chen","year":"2025","journal-title":"J Clin Investig"},{"key":"10.1016\/j.numecd.2026.104618_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102292","article-title":"Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study","volume":"65","author":"Moon","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"5","key":"10.1016\/j.numecd.2026.104618_bib41","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/nu17050802","article-title":"Endothelial homeostasis under the influence of alcohol - relevance to atherosclerotic cardiovascular disease","volume":"17","author":"Gusti","year":"2025","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.numecd.2026.104618_bib42","doi-asserted-by":"crossref","first-page":"C1637","DOI":"10.1152\/ajpcell.00951.2024","article-title":"Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease","volume":"328","author":"Kuchay","year":"2025","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.numecd.2026.104618_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1244405","article-title":"Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease","volume":"14","author":"Semmler","year":"2023","journal-title":"Front Endocrinol"},{"issue":"34","key":"10.1016\/j.numecd.2026.104618_bib44","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.numecd.2026.104618_bib45","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States","volume":"75","author":"Kim","year":"2021","journal-title":"J Hepatol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326000803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326000803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:06:19Z","timestamp":1790082379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475326000803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0939475326000803"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104618","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atherosclerosis burden across subtypes of steatotic liver disease: a European cohort analysis","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}],"article-number":"104618"}}